All the shares are tendered to take effect during this subsequent offering period will be immediately accepted for payment, and tendering stockholders will be paid thereafter tendered promptly $ 43 main causes of ed .00 in cash for each share of Cougar Biotechnology common stock, without interest and less any required withholding taxes. This is the same amount per share that are offered and paid in the initial offering period.
The offer was a wholly owned subsidiary of Johnson & Johnson named Kite Merger Sub, performed The depositary for the tender offer has advised Johnson & Johnson, as the end of the initial offer period, a total of 17,030 shares of Cougar Biotechnology common stock were properly tendered and not withdrawn, what. Approximately 84.4 percent of the outstanding shares of Cougar Biotechnology common stock All shares properly properly and not properly withdrawn during the initial offering period have been accepted for payment.
Character, Continue the efforts to overhaul health care influence of.